Suppr超能文献

CDK9 乙酰化对 P-TEFb 延伸复合物活性的调控。

Regulation of P-TEFb elongation complex activity by CDK9 acetylation.

作者信息

Fu Junjiang, Yoon Ho-Geun, Qin Jun, Wong Jiemin

机构信息

Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.

出版信息

Mol Cell Biol. 2007 Jul;27(13):4641-51. doi: 10.1128/MCB.00857-06. Epub 2007 Apr 23.

Abstract

P-TEFb, comprised of CDK9 and a cyclin T subunit, is a global transcriptional elongation factor important for most RNA polymerase II (pol II) transcription. P-TEFb facilitates transcription elongation in part by phosphorylating Ser2 of the heptapeptide repeat of the carboxy-terminal domain (CTD) of the largest subunit of pol II. Previous studies have shown that P-TEFb is subjected to negative regulation by forming an inactive complex with 7SK small RNA and HEXIM1. In an effort to investigate the molecular mechanism by which corepressor N-CoR mediates transcription repression, we identified HEXIM1 as an N-CoR-interacting protein. This finding led us to test whether the P-TEFb complex is regulated by acetylation. We demonstrate that CDK9 is an acetylated protein in cells and can be acetylated by p300 in vitro. Through both in vitro and in vivo assays, we identified lysine 44 of CDK9 as a major acetylation site. We present evidence that CDK9 is regulated by N-CoR and its associated HDAC3 and that acetylation of CDK9 affects its ability to phosphorylate the CTD of pol II. These results suggest that acetylation of CDK9 is an important posttranslational modification that is involved in regulating P-TEFb transcriptional elongation function.

摘要

P-TEFb由细胞周期蛋白依赖性激酶9(CDK9)和一个细胞周期蛋白T亚基组成,是一种对大多数RNA聚合酶II(pol II)转录至关重要的全局转录延伸因子。P-TEFb部分通过磷酸化pol II最大亚基羧基末端结构域(CTD)七肽重复序列的Ser2来促进转录延伸。先前的研究表明,P-TEFb通过与7SK小RNA和HEXIM1形成无活性复合物而受到负调控。为了研究共抑制因子N-CoR介导转录抑制的分子机制,我们鉴定出HEXIM1是一种与N-CoR相互作用的蛋白。这一发现促使我们测试P-TEFb复合物是否受乙酰化调节。我们证明CDK9在细胞中是一种乙酰化蛋白,并且在体外可被p300乙酰化。通过体外和体内实验,我们确定CDK9的赖氨酸44是主要的乙酰化位点。我们提供的证据表明,CDK9受N-CoR及其相关的组蛋白去乙酰化酶3(HDAC3)调节,并且CDK9的乙酰化会影响其磷酸化pol II CTD的能力。这些结果表明,CDK9的乙酰化是一种重要的翻译后修饰,参与调节P-TEFb的转录延伸功能。

相似文献

1
Regulation of P-TEFb elongation complex activity by CDK9 acetylation.
Mol Cell Biol. 2007 Jul;27(13):4641-51. doi: 10.1128/MCB.00857-06. Epub 2007 Apr 23.
3
Binding of the 7SK snRNA turns the HEXIM1 protein into a P-TEFb (CDK9/cyclin T) inhibitor.
EMBO J. 2004 Jul 7;23(13):2608-19. doi: 10.1038/sj.emboj.7600275. Epub 2004 Jun 17.
4
Acute hypoxia affects P-TEFb through HDAC3 and HEXIM1-dependent mechanism to promote gene-specific transcriptional repression.
Nucleic Acids Res. 2014 Aug;42(14):8954-69. doi: 10.1093/nar/gku611. Epub 2014 Jul 23.
7
Acetylation of cyclin T1 regulates the equilibrium between active and inactive P-TEFb in cells.
EMBO J. 2009 May 20;28(10):1407-17. doi: 10.1038/emboj.2009.99. Epub 2009 Apr 23.
10
The emerging picture of CDK9/P-TEFb: more than 20 years of advances since PITALRE.
Mol Biosyst. 2017 Jan 31;13(2):246-276. doi: 10.1039/c6mb00387g.

引用本文的文献

1
Tailored therapies for triple-negative breast cancer: current landscape and future perceptions.
Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar 3. doi: 10.1007/s00210-025-03896-4.
2
ADAM10 is a key player in the diagnosis, prognosis and metastasis of non-small cell lung cancer (NSCLC).
J Cancer. 2025 Feb 11;16(5):1736-1746. doi: 10.7150/jca.107236. eCollection 2025.
3
OTUD1 promotes hypertensive kidney fibrosis and injury by deubiquitinating CDK9 in renal epithelial cells.
Acta Pharmacol Sin. 2024 Apr;45(4):765-776. doi: 10.1038/s41401-023-01192-6. Epub 2023 Dec 18.
4
Targeting Histone Deacetylases 6 in Dual-Target Therapy of Cancer.
Pharmaceutics. 2023 Nov 3;15(11):2581. doi: 10.3390/pharmaceutics15112581.
5
The Role of Histone Deacetylases in Acute Lung Injury-Friend or Foe.
Int J Mol Sci. 2023 Apr 26;24(9):7876. doi: 10.3390/ijms24097876.
6
The role of protein acetylation in carcinogenesis and targeted drug discovery.
Front Endocrinol (Lausanne). 2022 Sep 12;13:972312. doi: 10.3389/fendo.2022.972312. eCollection 2022.
7
The speckle-type POZ protein (SPOP) inhibits breast cancer malignancy by destabilizing TWIST1.
Cell Death Discov. 2022 Sep 17;8(1):389. doi: 10.1038/s41420-022-01182-3.
8
Heterogeneity of Latency Establishment in the Different Human CD4 T Cell Subsets Stimulated with IL-15.
J Virol. 2022 May 25;96(10):e0037922. doi: 10.1128/jvi.00379-22. Epub 2022 May 2.
10
CDK9: A Comprehensive Review of Its Biology, and Its Role as a Potential Target for Anti-Cancer Agents.
Front Oncol. 2021 May 10;11:678559. doi: 10.3389/fonc.2021.678559. eCollection 2021.

本文引用的文献

2
Acetylation and deacetylation of non-histone proteins.
Gene. 2005 Dec 19;363:15-23. doi: 10.1016/j.gene.2005.09.010. Epub 2005 Nov 11.
3
Histone modifying enzymes and cancer: going beyond histones.
J Cell Biochem. 2005 Dec 15;96(6):1137-48. doi: 10.1002/jcb.20615.
4
Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4.
Mol Cell. 2005 Aug 19;19(4):535-45. doi: 10.1016/j.molcel.2005.06.029.
8
Cyclin-dependent kinase-9: an RNAPII kinase at the nexus of cardiac growth and death cascades.
Circ Res. 2004 Oct 29;95(9):867-76. doi: 10.1161/01.RES.0000146675.88354.04.
9
Elongation by RNA polymerase II: the short and long of it.
Genes Dev. 2004 Oct 15;18(20):2437-68. doi: 10.1101/gad.1235904.
10
Activation of cardiac Cdk9 represses PGC-1 and confers a predisposition to heart failure.
EMBO J. 2004 Sep 1;23(17):3559-69. doi: 10.1038/sj.emboj.7600351. Epub 2004 Aug 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验